NEW YORK (GenomeWeb News) – Nanogen has licensed its minor groove binder probe technology to Quest Diagnostics for use in human in vitro diagnostics tests.

Clinical lab firm Quest will pay Nanogen an undisclosed upfront fee and royalties based on sales of products that incorporate the MGB Probe technology.

Nanogen noted that licensing deals for the MGB Probe technology now represents the majority of Nanogen's revenues. It said that it has more than 40 reagent and kit products sold for IVD use usnder the MGB Alert and Q-PCR Alert brands.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.